drugset / Trial / NCT01924208
Tonsillar Cytokine Expression After Allergen and/or Virus Intervention
Phase 3
Unknown
180 enrolled
Turku University Hospital
Academy of Finland · collabEVO special government transfers, Turku, Finland · collabFoundation for Paediatric Research, Finland · collabJuselius Foundation, Helsinki, Finland · collab
RandomizedParallel-groupOpen-labelBasic science
Summary
Hypotheses 1. Immunotherapy induces tolerogenic effects to allergens in T cell regulation in tonsils. 2. Influenza vaccination induces a strong interferon response and decreases Th2 response in tonsils. 3. Influenza vaccination as an adjuvant on immunotherapy induces a better response to immunotherapy.
Timeline
- Start
- 2013-10
- Primary completion
- 2016-09
- Completion
- 2016-09
Publications
- Background Kucuksezer UC, Palomares O, Ruckert B, Jartti T, Puhakka T, Nandy A, Gemicioglu B, Fahrner HB, Jung A, Deniz G, Akdis CA, Akdis M. Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen-specific T-cell tolerance in human tonsils and peripheral blood. J Allergy Clin Immunol. 2013 Mar;131(3):875-85. doi: 10.1016/j.jaci.2012.10.051. Epub 2012 Dec 23.
- Background Palomares O, Ruckert B, Jartti T, Kucuksezer UC, Puhakka T, Gomez E, Fahrner HB, Speiser A, Jung A, Kwok WW, Kalogjera L, Akdis M, Akdis CA. Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance. J Allergy Clin Immunol. 2012 Feb;129(2):510-20, 520.e1-9. doi: 10.1016/j.jaci.2011.09.031. Epub 2011 Nov 3.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Live attenuated influenza virus | Vaccine | 0.2 ml | Intranasal |
| Comparator | Timothy, Phleum pretense | Unknown | 75000 unknown | Other |
Indications
No indication recorded.